There’s been a remarkable shift in the exploration of minor cannabinoids and their potential to fuel major breakthroughs on a wide range of health issues, including obesity, sleep disorders, and even dementia-related diseases. This session delves into the exciting world of minor cannabinoids, shedding light on how their increased availability is igniting novel research and exploring the profound implications for patients. With the tools and resources at our disposal, we now have the opportunity to study these compounds closely, unlock their therapeutic potential and revolutionize healthcare.